Capricor Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $53.6. The average 1-year stock price forecast is 122.59% higher than the current stock price, while the lowest is $38 (+57.81%) and the highest is $63 (+161.63%).

Price Target: $53.6 (+122.59%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$38	$53.6	$52.5	$63
Change	+57.81%	+122.59%	+118.02%	+161.63%

Analyst Ratings

The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	8	8	8	7	7	8
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	9	9	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $60	Buy	Reiterates	$60	+149.17%	Jun 26, 2026
Leland Gershell Oppenheimer	Oppenheimer	Buy Reiterates $54	Buy	Reiterates	$54	+124.25%	Jun 18, 2026
Boobalan Pachaiyappan Roth MKM	Roth MKM	Buy Reiterates $38	Buy	Reiterates	$38	+57.81%	May 29, 2026
Matthew Venezia Alliance Global Partners	Alliance Global Partners	Buy Reiterates $51	Buy	Reiterates	$51	+111.79%	May 14, 2026
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $62	Buy	Maintains	$62	+157.48%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

118.08M

Revenue Next Year

122.34M

from 118.08M

3.61%

from 118.08M

EPS This Year

-0.22

from -2.26

EPS Next Year

-0.64

from -0.22

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	244.90K	2.55M	25.18M	22.27M	-	118.08M
Gross Profit	-13.33M	-19.27M	-11.27M	-27.70M	-84.45M	101.55M
Gross Margin	-5,441.51%	-755.07%	-44.76%	-124.37%	-	86.00%
Operating Income	-20.94M	-29.70M	-24.08M	-42.56M	-108.14M	-21.49M
Net Income	-20.02M	-29.02M	-22.29M	-40.47M	-105.04M	-28.40M
EPS	-	-	-	-	-2.26	-0.22
Free Cash Flow	-10.62M	2.34M	-10.92M	-27.78M	-39.60M	69.00M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	242.2M
Avg	118.1M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	139.6%
Avg	3.6%
Low	-92.6%

EPS Forecast

EPS	2026	2027	2028
High	1.70
Avg	-0.22
Low	-2.52

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-